Marie L.S. Lindegaard

Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity

Mikhail Kosiborod, Steen Z. Abildstrøm, Barry A. Borlaug et al. · New England Journal of Medicine · 2023 · 1.4K citations · Full text

Medicine, Cardiology, Pharmacology +17

Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes

Mikhail Kosiborod, Mark C. Petrie, Barry A. Borlaug et al. · New England Journal of Medicine · 2024 · 632 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +14

Cardiac Lipid Accumulation Associated with Diastolic Dysfunction in Obese Mice

Christina Christoffersen, Entela Bollano, Marie L.S. Lindegaard et al. · Endocrinology · 2003 · 371 citations · Full text

Life Sciences, Cardiology, Physiology +17

Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials

Javed Butler, Sanjiv J. Shah, Mark C. Petrie et al. · The Lancet · 2024 · 323 citations · Full text

Medicine, Cardiology, Pharmacology +10

A Phase 2, Randomized, Dose-Finding Study of the Novel Once-Weekly Human GLP-1 Analog, Semaglutide, Compared With Placebo and Open-Label Liraglutide in Patients With Type 2 Diabetes

Michael A. Nauck, John R. Petrie, Giorgio Sesti et al. · Diabetes Care · 2015 · 224 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11